BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

  March 18, 2026

   · 

  2 min read
• Press Releases

  Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

  March 18, 2026

   · 

  7 min read
• Press Releases

  Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

  March 18, 2026

   · 

  5 min read
• Press Releases

  Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026

  March 18, 2026

   · 

  6 min read
• Press Releases

  Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy

  March 18, 2026

   · 

  3 min read
• Press Releases

  Evaxion to present new data at AACR Annual Meeting

  March 18, 2026

   · 

  4 min read
• Press Releases

  Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

  March 18, 2026

   · 

  3 min read
• Press Releases

  SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

  March 18, 2026

   · 

  4 min read
• Press Releases

  BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026

  March 18, 2026

   · 

  5 min read
• Press Releases

  Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

  March 18, 2026

   · 

  5 min read